img

Global Beta-Adrenoceptor Agonists Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Beta-Adrenoceptor Agonists Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Beta-adrenoceptor agonists (β-agonists) bind to the β-receptors on the smooth muscle tissues and cardiac tissues. They also have important actions in other tissues, especially bronchial smooth muscle, the liver, and kidneys. Beta-adrenoceptors usually bind to norepinephrine that is released by the sympathetic adrenergic nerves, and to circulating epinephrine. It is of great importance to the healthcare sector and thus is expected to rise high in the forecast period.
Beta-Adrenoceptor Agonists report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Beta-Adrenoceptor Agonists market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Asthma and Anaphylactic Shock are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Beta-Adrenoceptor Agonists industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Beta-Adrenoceptor Agonists key manufacturers include F. Hoffmann-La Roche Ltd, Mylan NV, Teva Pharmaceutical Industries Ltd, Sanofi, Pfizer Inc, GSK plc, Novartis AG, Bayer AG and Lilly, etc. F. Hoffmann-La Roche Ltd, Mylan NV, Teva Pharmaceutical Industries Ltd are top 3 players and held % sales share in total in 2022.
Beta-Adrenoceptor Agonists can be divided into β 1 Agonist and β 2 Agonists, etc. β 1 Agonist is the mainstream product in the market, accounting for % sales share globally in 2022.
Beta-Adrenoceptor Agonists is widely used in various fields, such as Asthma, Anaphylactic Shock, Severe Hypotension and Acute Heart Failure, etc. Asthma provides greatest supports to the Beta-Adrenoceptor Agonists industry development. In 2022, global % sales of Beta-Adrenoceptor Agonists went into Asthma filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Beta-Adrenoceptor Agonists market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


F. Hoffmann-La Roche Ltd
Mylan NV
Teva Pharmaceutical Industries Ltd
Sanofi
Pfizer Inc
GSK plc
Novartis AG
Bayer AG
Lilly
Merck & Co., Inc
Sun Pharmaceutical Industries Ltd
Aurobindo Pharma
Lupin
Amneal Pharmaceuticals LLC
Eisai Co., Ltd
Segment by Type
β 1 Agonist
β 2 Agonists

Segment by Application


Asthma
Anaphylactic Shock
Severe Hypotension
Acute Heart Failure
Acute Renal Failure
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Beta-Adrenoceptor Agonists market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Beta-Adrenoceptor Agonists, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Beta-Adrenoceptor Agonists industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Beta-Adrenoceptor Agonists in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Beta-Adrenoceptor Agonists introduction, etc. Beta-Adrenoceptor Agonists Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Beta-Adrenoceptor Agonists market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Beta-Adrenoceptor Agonists Market Overview
1.1 Beta-Adrenoceptor Agonists Product Overview
1.2 Beta-Adrenoceptor Agonists Market Segment by Type
1.2.1 β 1 Agonist
1.2.2 β 2 Agonists
1.3 Global Beta-Adrenoceptor Agonists Market Size by Type
1.3.1 Global Beta-Adrenoceptor Agonists Market Size Overview by Type (2018-2029)
1.3.2 Global Beta-Adrenoceptor Agonists Historic Market Size Review by Type (2018-2024)
1.3.3 Global Beta-Adrenoceptor Agonists Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Beta-Adrenoceptor Agonists Sales Breakdown by Type (2018-2024)
1.4.2 Europe Beta-Adrenoceptor Agonists Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Beta-Adrenoceptor Agonists Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Beta-Adrenoceptor Agonists Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Beta-Adrenoceptor Agonists Sales Breakdown by Type (2018-2024)
2 Global Beta-Adrenoceptor Agonists Market Competition by Company
2.1 Global Top Players by Beta-Adrenoceptor Agonists Sales (2018-2024)
2.2 Global Top Players by Beta-Adrenoceptor Agonists Revenue (2018-2024)
2.3 Global Top Players by Beta-Adrenoceptor Agonists Price (2018-2024)
2.4 Global Top Manufacturers Beta-Adrenoceptor Agonists Manufacturing Base Distribution, Sales Area, Product Type
2.5 Beta-Adrenoceptor Agonists Market Competitive Situation and Trends
2.5.1 Beta-Adrenoceptor Agonists Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Beta-Adrenoceptor Agonists Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Beta-Adrenoceptor Agonists as of 2022)
2.7 Date of Key Manufacturers Enter into Beta-Adrenoceptor Agonists Market
2.8 Key Manufacturers Beta-Adrenoceptor Agonists Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Beta-Adrenoceptor Agonists Status and Outlook by Region
3.1 Global Beta-Adrenoceptor Agonists Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Beta-Adrenoceptor Agonists Historic Market Size by Region
3.2.1 Global Beta-Adrenoceptor Agonists Sales in Volume by Region (2018-2024)
3.2.2 Global Beta-Adrenoceptor Agonists Sales in Value by Region (2018-2024)
3.2.3 Global Beta-Adrenoceptor Agonists Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Beta-Adrenoceptor Agonists Forecasted Market Size by Region
3.3.1 Global Beta-Adrenoceptor Agonists Sales in Volume by Region (2024-2029)
3.3.2 Global Beta-Adrenoceptor Agonists Sales in Value by Region (2024-2029)
3.3.3 Global Beta-Adrenoceptor Agonists Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Beta-Adrenoceptor Agonists by Application
4.1 Beta-Adrenoceptor Agonists Market Segment by Application
4.1.1 Asthma
4.1.2 Anaphylactic Shock
4.1.3 Severe Hypotension
4.1.4 Acute Heart Failure
4.1.5 Acute Renal Failure
4.1.6 Other
4.2 Global Beta-Adrenoceptor Agonists Market Size by Application
4.2.1 Global Beta-Adrenoceptor Agonists Market Size Overview by Application (2018-2029)
4.2.2 Global Beta-Adrenoceptor Agonists Historic Market Size Review by Application (2018-2024)
4.2.3 Global Beta-Adrenoceptor Agonists Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Beta-Adrenoceptor Agonists Sales Breakdown by Application (2018-2024)
4.3.2 Europe Beta-Adrenoceptor Agonists Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Beta-Adrenoceptor Agonists Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Beta-Adrenoceptor Agonists Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Beta-Adrenoceptor Agonists Sales Breakdown by Application (2018-2024)
5 North America Beta-Adrenoceptor Agonists by Country
5.1 North America Beta-Adrenoceptor Agonists Historic Market Size by Country
5.1.1 North America Beta-Adrenoceptor Agonists Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Beta-Adrenoceptor Agonists Sales in Volume by Country (2018-2024)
5.1.3 North America Beta-Adrenoceptor Agonists Sales in Value by Country (2018-2024)
5.2 North America Beta-Adrenoceptor Agonists Forecasted Market Size by Country
5.2.1 North America Beta-Adrenoceptor Agonists Sales in Volume by Country (2024-2029)
5.2.2 North America Beta-Adrenoceptor Agonists Sales in Value by Country (2024-2029)
6 Europe Beta-Adrenoceptor Agonists by Country
6.1 Europe Beta-Adrenoceptor Agonists Historic Market Size by Country
6.1.1 Europe Beta-Adrenoceptor Agonists Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Beta-Adrenoceptor Agonists Sales in Volume by Country (2018-2024)
6.1.3 Europe Beta-Adrenoceptor Agonists Sales in Value by Country (2018-2024)
6.2 Europe Beta-Adrenoceptor Agonists Forecasted Market Size by Country
6.2.1 Europe Beta-Adrenoceptor Agonists Sales in Volume by Country (2024-2029)
6.2.2 Europe Beta-Adrenoceptor Agonists Sales in Value by Country (2024-2029)
7 Asia-Pacific Beta-Adrenoceptor Agonists by Region
7.1 Asia-Pacific Beta-Adrenoceptor Agonists Historic Market Size by Region
7.1.1 Asia-Pacific Beta-Adrenoceptor Agonists Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Beta-Adrenoceptor Agonists Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Beta-Adrenoceptor Agonists Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Beta-Adrenoceptor Agonists Forecasted Market Size by Region
7.2.1 Asia-Pacific Beta-Adrenoceptor Agonists Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Beta-Adrenoceptor Agonists Sales in Value by Region (2024-2029)
8 Latin America Beta-Adrenoceptor Agonists by Country
8.1 Latin America Beta-Adrenoceptor Agonists Historic Market Size by Country
8.1.1 Latin America Beta-Adrenoceptor Agonists Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Beta-Adrenoceptor Agonists Sales in Volume by Country (2018-2024)
8.1.3 Latin America Beta-Adrenoceptor Agonists Sales in Value by Country (2018-2024)
8.2 Latin America Beta-Adrenoceptor Agonists Forecasted Market Size by Country
8.2.1 Latin America Beta-Adrenoceptor Agonists Sales in Volume by Country (2024-2029)
8.2.2 Latin America Beta-Adrenoceptor Agonists Sales in Value by Country (2024-2029)
9 Middle East and Africa Beta-Adrenoceptor Agonists by Country
9.1 Middle East and Africa Beta-Adrenoceptor Agonists Historic Market Size by Country
9.1.1 Middle East and Africa Beta-Adrenoceptor Agonists Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Beta-Adrenoceptor Agonists Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Beta-Adrenoceptor Agonists Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Beta-Adrenoceptor Agonists Forecasted Market Size by Country
9.2.1 Middle East and Africa Beta-Adrenoceptor Agonists Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Beta-Adrenoceptor Agonists Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 F. Hoffmann-La Roche Ltd
10.1.1 F. Hoffmann-La Roche Ltd Company Information
10.1.2 F. Hoffmann-La Roche Ltd Introduction and Business Overview
10.1.3 F. Hoffmann-La Roche Ltd Beta-Adrenoceptor Agonists Sales, Revenue and Gross Margin (2018-2024)
10.1.4 F. Hoffmann-La Roche Ltd Beta-Adrenoceptor Agonists Products Offered
10.1.5 F. Hoffmann-La Roche Ltd Recent Development
10.2 Mylan NV
10.2.1 Mylan NV Company Information
10.2.2 Mylan NV Introduction and Business Overview
10.2.3 Mylan NV Beta-Adrenoceptor Agonists Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Mylan NV Beta-Adrenoceptor Agonists Products Offered
10.2.5 Mylan NV Recent Development
10.3 Teva Pharmaceutical Industries Ltd
10.3.1 Teva Pharmaceutical Industries Ltd Company Information
10.3.2 Teva Pharmaceutical Industries Ltd Introduction and Business Overview
10.3.3 Teva Pharmaceutical Industries Ltd Beta-Adrenoceptor Agonists Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Teva Pharmaceutical Industries Ltd Beta-Adrenoceptor Agonists Products Offered
10.3.5 Teva Pharmaceutical Industries Ltd Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Beta-Adrenoceptor Agonists Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Sanofi Beta-Adrenoceptor Agonists Products Offered
10.4.5 Sanofi Recent Development
10.5 Pfizer Inc
10.5.1 Pfizer Inc Company Information
10.5.2 Pfizer Inc Introduction and Business Overview
10.5.3 Pfizer Inc Beta-Adrenoceptor Agonists Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Pfizer Inc Beta-Adrenoceptor Agonists Products Offered
10.5.5 Pfizer Inc Recent Development
10.6 GSK plc
10.6.1 GSK plc Company Information
10.6.2 GSK plc Introduction and Business Overview
10.6.3 GSK plc Beta-Adrenoceptor Agonists Sales, Revenue and Gross Margin (2018-2024)
10.6.4 GSK plc Beta-Adrenoceptor Agonists Products Offered
10.6.5 GSK plc Recent Development
10.7 Novartis AG
10.7.1 Novartis AG Company Information
10.7.2 Novartis AG Introduction and Business Overview
10.7.3 Novartis AG Beta-Adrenoceptor Agonists Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Novartis AG Beta-Adrenoceptor Agonists Products Offered
10.7.5 Novartis AG Recent Development
10.8 Bayer AG
10.8.1 Bayer AG Company Information
10.8.2 Bayer AG Introduction and Business Overview
10.8.3 Bayer AG Beta-Adrenoceptor Agonists Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Bayer AG Beta-Adrenoceptor Agonists Products Offered
10.8.5 Bayer AG Recent Development
10.9 Lilly
10.9.1 Lilly Company Information
10.9.2 Lilly Introduction and Business Overview
10.9.3 Lilly Beta-Adrenoceptor Agonists Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Lilly Beta-Adrenoceptor Agonists Products Offered
10.9.5 Lilly Recent Development
10.10 Merck & Co., Inc
10.10.1 Merck & Co., Inc Company Information
10.10.2 Merck & Co., Inc Introduction and Business Overview
10.10.3 Merck & Co., Inc Beta-Adrenoceptor Agonists Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Merck & Co., Inc Beta-Adrenoceptor Agonists Products Offered
10.10.5 Merck & Co., Inc Recent Development
10.11 Sun Pharmaceutical Industries Ltd
10.11.1 Sun Pharmaceutical Industries Ltd Company Information
10.11.2 Sun Pharmaceutical Industries Ltd Introduction and Business Overview
10.11.3 Sun Pharmaceutical Industries Ltd Beta-Adrenoceptor Agonists Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Sun Pharmaceutical Industries Ltd Beta-Adrenoceptor Agonists Products Offered
10.11.5 Sun Pharmaceutical Industries Ltd Recent Development
10.12 Aurobindo Pharma
10.12.1 Aurobindo Pharma Company Information
10.12.2 Aurobindo Pharma Introduction and Business Overview
10.12.3 Aurobindo Pharma Beta-Adrenoceptor Agonists Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Aurobindo Pharma Beta-Adrenoceptor Agonists Products Offered
10.12.5 Aurobindo Pharma Recent Development
10.13 Lupin
10.13.1 Lupin Company Information
10.13.2 Lupin Introduction and Business Overview
10.13.3 Lupin Beta-Adrenoceptor Agonists Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Lupin Beta-Adrenoceptor Agonists Products Offered
10.13.5 Lupin Recent Development
10.14 Amneal Pharmaceuticals LLC
10.14.1 Amneal Pharmaceuticals LLC Company Information
10.14.2 Amneal Pharmaceuticals LLC Introduction and Business Overview
10.14.3 Amneal Pharmaceuticals LLC Beta-Adrenoceptor Agonists Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Amneal Pharmaceuticals LLC Beta-Adrenoceptor Agonists Products Offered
10.14.5 Amneal Pharmaceuticals LLC Recent Development
10.15 Eisai Co., Ltd
10.15.1 Eisai Co., Ltd Company Information
10.15.2 Eisai Co., Ltd Introduction and Business Overview
10.15.3 Eisai Co., Ltd Beta-Adrenoceptor Agonists Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Eisai Co., Ltd Beta-Adrenoceptor Agonists Products Offered
10.15.5 Eisai Co., Ltd Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Beta-Adrenoceptor Agonists Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Beta-Adrenoceptor Agonists Industrial Chain Analysis
11.4 Beta-Adrenoceptor Agonists Market Dynamics
11.4.1 Beta-Adrenoceptor Agonists Industry Trends
11.4.2 Beta-Adrenoceptor Agonists Market Drivers
11.4.3 Beta-Adrenoceptor Agonists Market Challenges
11.4.4 Beta-Adrenoceptor Agonists Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Beta-Adrenoceptor Agonists Distributors
12.3 Beta-Adrenoceptor Agonists Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of β 1 Agonist
Table 2. Major Company of β 2 Agonists
Table 3. Global Beta-Adrenoceptor Agonists Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Beta-Adrenoceptor Agonists Sales by Type (2018-2024) & (K Units)
Table 5. Global Beta-Adrenoceptor Agonists Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Beta-Adrenoceptor Agonists Sales by Type (2018-2024) & (US& Million)
Table 7. Global Beta-Adrenoceptor Agonists Market Share in Value by Type (2018-2024)
Table 8. Global Beta-Adrenoceptor Agonists Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Beta-Adrenoceptor Agonists Sales by Type (2024-2029) & (K Units)
Table 10. Global Beta-Adrenoceptor Agonists Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Beta-Adrenoceptor Agonists Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Beta-Adrenoceptor Agonists Sales Market Share in Value by Type (2024-2029)
Table 13. Global Beta-Adrenoceptor Agonists Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Beta-Adrenoceptor Agonists Sales by Type (2018-2024) & (K Units)
Table 15. North America Beta-Adrenoceptor Agonists Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Beta-Adrenoceptor Agonists Sales (K Units) by Type (2018-2024)
Table 17. Europe Beta-Adrenoceptor Agonists Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Beta-Adrenoceptor Agonists Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Beta-Adrenoceptor Agonists Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Beta-Adrenoceptor Agonists Sales (K Units) by Type (2018-2024)
Table 21. Latin America Beta-Adrenoceptor Agonists Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Beta-Adrenoceptor Agonists Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Beta-Adrenoceptor Agonists Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Beta-Adrenoceptor Agonists Sales by Company (2018-2024) & (K Units)
Table 25. Global Beta-Adrenoceptor Agonists Sales Share by Company (2018-2024)
Table 26. Global Beta-Adrenoceptor Agonists Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Beta-Adrenoceptor Agonists Revenue Share by Company (2018-2024)
Table 28. Global Market Beta-Adrenoceptor Agonists Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Beta-Adrenoceptor Agonists Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Beta-Adrenoceptor Agonists Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Beta-Adrenoceptor Agonists as of 2022)
Table 32. Date of Key Manufacturers Enter into Beta-Adrenoceptor Agonists Market
Table 33. Key Manufacturers Beta-Adrenoceptor Agonists Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Beta-Adrenoceptor Agonists Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Beta-Adrenoceptor Agonists Sales by Region (2018-2024) & (K Units)
Table 37. Global Beta-Adrenoceptor Agonists Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Beta-Adrenoceptor Agonists Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Beta-Adrenoceptor Agonists Sales Market Share in Value by Region (2018-2024)
Table 40. Global Beta-Adrenoceptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Beta-Adrenoceptor Agonists Sales by Region (2024-2029) & (K Units)
Table 42. Global Beta-Adrenoceptor Agonists Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Beta-Adrenoceptor Agonists Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Beta-Adrenoceptor Agonists Sales Market Share in Value by Region (2024-2029)
Table 45. Global Beta-Adrenoceptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Beta-Adrenoceptor Agonists Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Beta-Adrenoceptor Agonists Sales by Application (2018-2024) & (K Units)
Table 48. Global Beta-Adrenoceptor Agonists Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Beta-Adrenoceptor Agonists Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Beta-Adrenoceptor Agonists Sales Market Share in Value by Application (2018-2024)
Table 51. Global Beta-Adrenoceptor Agonists Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Beta-Adrenoceptor Agonists Sales by Application (2024-2029) & (K Units)
Table 53. Global Beta-Adrenoceptor Agonists Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Beta-Adrenoceptor Agonists Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Beta-Adrenoceptor Agonists Sales Market Share in Value by Application (2024-2029)
Table 56. Global Beta-Adrenoceptor Agonists Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Beta-Adrenoceptor Agonists Sales by Application (2018-2024) (K Units)
Table 58. North America Beta-Adrenoceptor Agonists Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Beta-Adrenoceptor Agonists Sales by Application (2018-2024) (K Units)
Table 60. Europe Beta-Adrenoceptor Agonists Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Beta-Adrenoceptor Agonists Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Beta-Adrenoceptor Agonists Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Beta-Adrenoceptor Agonists Sales by Application (2018-2024) (K Units)
Table 64. Latin America Beta-Adrenoceptor Agonists Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Beta-Adrenoceptor Agonists Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Beta-Adrenoceptor Agonists Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Beta-Adrenoceptor Agonists Sales by Country (2018-2024) & (K Units)
Table 68. North America Beta-Adrenoceptor Agonists Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Beta-Adrenoceptor Agonists Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Beta-Adrenoceptor Agonists Sales Market Share in Value by Country (2018-2024)
Table 71. North America Beta-Adrenoceptor Agonists Sales by Country (2024-2029) & (K Units)
Table 72. North America Beta-Adrenoceptor Agonists Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Beta-Adrenoceptor Agonists Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Beta-Adrenoceptor Agonists Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Beta-Adrenoceptor Agonists Sales by Country (2018-2024) & (K Units)
Table 76. Europe Beta-Adrenoceptor Agonists Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Beta-Adrenoceptor Agonists Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Beta-Adrenoceptor Agonists Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Beta-Adrenoceptor Agonists Sales by Country (2024-2029) & (K Units)
Table 80. Europe Beta-Adrenoceptor Agonists Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Beta-Adrenoceptor Agonists Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Beta-Adrenoceptor Agonists Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Beta-Adrenoceptor Agonists Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Beta-Adrenoceptor Agonists Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Beta-Adrenoceptor Agonists Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Beta-Adrenoceptor Agonists Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Beta-Adrenoceptor Agonists Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Beta-Adrenoceptor Agonists Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Beta-Adrenoceptor Agonists Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Beta-Adrenoceptor Agonists Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Beta-Adrenoceptor Agonists Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Beta-Adrenoceptor Agonists Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Beta-Adrenoceptor Agonists Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Beta-Adrenoceptor Agonists Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Beta-Adrenoceptor Agonists Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Beta-Adrenoceptor Agonists Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Beta-Adrenoceptor Agonists Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Beta-Adrenoceptor Agonists Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Beta-Adrenoceptor Agonists Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Beta-Adrenoceptor Agonists Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Beta-Adrenoceptor Agonists Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Beta-Adrenoceptor Agonists Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Beta-Adrenoceptor Agonists Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Beta-Adrenoceptor Agonists Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Beta-Adrenoceptor Agonists Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Beta-Adrenoceptor Agonists Sales Market Share in Value by Country (2024-2029)
Table 107. F. Hoffmann-La Roche Ltd Company Information
Table 108. F. Hoffmann-La Roche Ltd Introduction and Business Overview
Table 109. F. Hoffmann-La Roche Ltd Beta-Adrenoceptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. F. Hoffmann-La Roche Ltd Beta-Adrenoceptor Agonists Product
Table 111. F. Hoffmann-La Roche Ltd Recent Development
Table 112. Mylan NV Company Information
Table 113. Mylan NV Introduction and Business Overview
Table 114. Mylan NV Beta-Adrenoceptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Mylan NV Beta-Adrenoceptor Agonists Product
Table 116. Mylan NV Recent Development
Table 117. Teva Pharmaceutical Industries Ltd Company Information
Table 118. Teva Pharmaceutical Industries Ltd Introduction and Business Overview
Table 119. Teva Pharmaceutical Industries Ltd Beta-Adrenoceptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Teva Pharmaceutical Industries Ltd Beta-Adrenoceptor Agonists Product
Table 121. Teva Pharmaceutical Industries Ltd Recent Development
Table 122. Sanofi Company Information
Table 123. Sanofi Introduction and Business Overview
Table 124. Sanofi Beta-Adrenoceptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Sanofi Beta-Adrenoceptor Agonists Product
Table 126. Sanofi Recent Development
Table 127. Pfizer Inc Company Information
Table 128. Pfizer Inc Introduction and Business Overview
Table 129. Pfizer Inc Beta-Adrenoceptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Pfizer Inc Beta-Adrenoceptor Agonists Product
Table 131. Pfizer Inc Recent Development
Table 132. GSK plc Company Information
Table 133. GSK plc Introduction and Business Overview
Table 134. GSK plc Beta-Adrenoceptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. GSK plc Beta-Adrenoceptor Agonists Product
Table 136. GSK plc Recent Development
Table 137. Novartis AG Company Information
Table 138. Novartis AG Introduction and Business Overview
Table 139. Novartis AG Beta-Adrenoceptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Novartis AG Beta-Adrenoceptor Agonists Product
Table 141. Novartis AG Recent Development
Table 142. Bayer AG Company Information
Table 143. Bayer AG Introduction and Business Overview
Table 144. Bayer AG Beta-Adrenoceptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Bayer AG Beta-Adrenoceptor Agonists Product
Table 146. Bayer AG Recent Development
Table 147. Lilly Company Information
Table 148. Lilly Introduction and Business Overview
Table 149. Lilly Beta-Adrenoceptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Lilly Beta-Adrenoceptor Agonists Product
Table 151. Lilly Recent Development
Table 152. Merck & Co., Inc Company Information
Table 153. Merck & Co., Inc Introduction and Business Overview
Table 154. Merck & Co., Inc Beta-Adrenoceptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Merck & Co., Inc Beta-Adrenoceptor Agonists Product
Table 156. Merck & Co., Inc Recent Development
Table 157. Sun Pharmaceutical Industries Ltd Company Information
Table 158. Sun Pharmaceutical Industries Ltd Introduction and Business Overview
Table 159. Sun Pharmaceutical Industries Ltd Beta-Adrenoceptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Sun Pharmaceutical Industries Ltd Beta-Adrenoceptor Agonists Product
Table 161. Sun Pharmaceutical Industries Ltd Recent Development
Table 162. Aurobindo Pharma Company Information
Table 163. Aurobindo Pharma Introduction and Business Overview
Table 164. Aurobindo Pharma Beta-Adrenoceptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Aurobindo Pharma Beta-Adrenoceptor Agonists Product
Table 166. Aurobindo Pharma Recent Development
Table 167. Lupin Company Information
Table 168. Lupin Introduction and Business Overview
Table 169. Lupin Beta-Adrenoceptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Lupin Beta-Adrenoceptor Agonists Product
Table 171. Lupin Recent Development
Table 172. Amneal Pharmaceuticals LLC Company Information
Table 173. Amneal Pharmaceuticals LLC Introduction and Business Overview
Table 174. Amneal Pharmaceuticals LLC Beta-Adrenoceptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Amneal Pharmaceuticals LLC Beta-Adrenoceptor Agonists Product
Table 176. Amneal Pharmaceuticals LLC Recent Development
Table 177. Eisai Co., Ltd Company Information
Table 178. Eisai Co., Ltd Introduction and Business Overview
Table 179. Eisai Co., Ltd Beta-Adrenoceptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Eisai Co., Ltd Beta-Adrenoceptor Agonists Product
Table 181. Eisai Co., Ltd Recent Development
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Beta-Adrenoceptor Agonists Market Trends
Table 185. Beta-Adrenoceptor Agonists Market Drivers
Table 186. Beta-Adrenoceptor Agonists Market Challenges
Table 187. Beta-Adrenoceptor Agonists Market Restraints
Table 188. Beta-Adrenoceptor Agonists Distributors List
Table 189. Beta-Adrenoceptor Agonists Downstream Customers
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Beta-Adrenoceptor Agonists Product Picture
Figure 2. Global Beta-Adrenoceptor Agonists Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Beta-Adrenoceptor Agonists Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Beta-Adrenoceptor Agonists Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of β 1 Agonist
Figure 6. Global β 1 Agonist Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of β 2 Agonists
Figure 8. Global β 2 Agonists Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Beta-Adrenoceptor Agonists Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Beta-Adrenoceptor Agonists Sales Market Share by Type in 2022 & 2029
Figure 11. North America Beta-Adrenoceptor Agonists Sales Market Share in Volume by Type in 2022
Figure 12. North America Beta-Adrenoceptor Agonists Sales Market Share in Value by Type in 2022
Figure 13. Europe Beta-Adrenoceptor Agonists Sales Market Share in Volume by Type in 2022
Figure 14. Europe Beta-Adrenoceptor Agonists Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Beta-Adrenoceptor Agonists Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Beta-Adrenoceptor Agonists Sales Market Share in Value by Type in 2022
Figure 17. Latin America Beta-Adrenoceptor Agonists Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Beta-Adrenoceptor Agonists Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Beta-Adrenoceptor Agonists Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Beta-Adrenoceptor Agonists Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Beta-Adrenoceptor Agonists Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Beta-Adrenoceptor Agonists Revenue in 2022
Figure 23. Beta-Adrenoceptor Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Asthma
Figure 25. Global Asthma Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Anaphylactic Shock
Figure 27. Global Anaphylactic Shock Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Severe Hypotension
Figure 29. Global Severe Hypotension Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Acute Heart Failure
Figure 31. Global Acute Heart Failure Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Acute Renal Failure
Figure 33. Global Acute Renal Failure Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Product Picture of Other
Figure 35. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 36. Global Beta-Adrenoceptor Agonists Sales by Application (2018-2029) & (US$ Million)
Figure 37. Global Beta-Adrenoceptor Agonists Sales Market Share by Application in 2022 & 2029
Figure 38. North America Beta-Adrenoceptor Agonists Sales Market Share in Volume by Application in 2022
Figure 39. North America Beta-Adrenoceptor Agonists Sales Market Share in Value by Application in 2022
Figure 40. Europe Beta-Adrenoceptor Agonists Sales Market Share in Volume by Application in 2022
Figure 41. Europe Beta-Adrenoceptor Agonists Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Beta-Adrenoceptor Agonists Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Beta-Adrenoceptor Agonists Sales Market Share in Value by Application in 2022
Figure 44. Latin America Beta-Adrenoceptor Agonists Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Beta-Adrenoceptor Agonists Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Beta-Adrenoceptor Agonists Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Beta-Adrenoceptor Agonists Manufacturing Cost Structure
Figure 49. Beta-Adrenoceptor Agonists Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries